Karen Bartley

568 total citations
27 papers, 336 citations indexed

About

Karen Bartley is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Karen Bartley has authored 27 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Karen Bartley's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Advanced Breast Cancer Therapies (5 papers) and Melanoma and MAPK Pathways (4 papers). Karen Bartley is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Advanced Breast Cancer Therapies (5 papers) and Melanoma and MAPK Pathways (4 papers). Karen Bartley collaborates with scholars based in United States, Switzerland and Belgium. Karen Bartley's co-authors include Catherine Metayer, Patricia A. Buffler, Steve Selvin, Jonathan M. Ducore, Melinda C. Aldrich, Klaus-Uwe Kirchgaessler, Joseph L. Wiemels, Jeffrey S. Chang, Wim Wuyts and Hans Slabbynck and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Epidemiology.

In The Last Decade

Karen Bartley

25 papers receiving 328 citations

Peers

Karen Bartley
Flora E. van Leeuwen Netherlands
Timothy A. Zaki United States
Deepa Dhawan India
Maria Komisarenko Canada
Louise M. Rasmussen Denmark
Jennifer Woo United States
Luis Alberto More United States
Margaret Cupit-Link United States
Stephanie B. Dixon United States
Tayup Şimşek Türkiye
Flora E. van Leeuwen Netherlands
Karen Bartley
Citations per year, relative to Karen Bartley Karen Bartley (= 1×) peers Flora E. van Leeuwen

Countries citing papers authored by Karen Bartley

Since Specialization
Citations

This map shows the geographic impact of Karen Bartley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Bartley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Bartley more than expected).

Fields of papers citing papers by Karen Bartley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Bartley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Bartley. The network helps show where Karen Bartley may publish in the future.

Co-authorship network of co-authors of Karen Bartley

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Bartley. A scholar is included among the top collaborators of Karen Bartley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Bartley. Karen Bartley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bartley, Karen, et al.. (2025). The prognostic impact of human epidermal growth factor receptor 2 status in metastatic colorectal cancer. Future Science OA. 11(1). 2527482–2527482. 1 indexed citations
3.
Anders, Carey K., et al.. (2024). Real-world clinical outcomes in patients with HER2+ metastatic breast cancer receiving tucatinib therapy after 2 or more prior HER2-directed therapies. European Journal of Cancer. 200. 113621–113621. 1 indexed citations
4.
Kaufman, Peter A., Naomi Schwartz, Shu Wang, et al.. (2023). Real-world patient characteristics, treatment patterns, and clinical outcomes associated with tucatinib therapy in HER2-positive metastatic breast cancer. Frontiers in Oncology. 13. 7 indexed citations
5.
Anders, Carey K., Naomi Schwartz, Karen Bartley, et al.. (2023). Real-world patient characteristics and treatment patterns associated with tucatinib therapy in patients with HER2+ metastatic breast cancer.. Journal of Clinical Oncology. 41(16_suppl). 1051–1051. 2 indexed citations
6.
Wuyts, Wim, Caroline Dahlqvist, Hans Slabbynck, et al.. (2022). Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry. Pulmonary Therapy. 8(2). 181–194. 7 indexed citations
7.
Tawbi, Hussein A., Tu My To, Karen Bartley, et al.. (2021). Treatment patterns and clinical outcomes for patients with melanoma and central nervous system metastases: A real‐world study. Cancer Medicine. 11(1). 139–150. 8 indexed citations
8.
Kahana, Alon, et al.. (2021). Healthcare Resource Utilization and Cost of Care in Patients With Periocular Basal Cell Carcinoma: A Real-World Study. American Journal of Ophthalmology. 236. 164–171. 2 indexed citations
9.
Wuyts, Wim, Caroline Dahlqvist, Hans Slabbynck, et al.. (2019). Longitudinal clinical outcomes in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry. Respiratory Research. 20(1). 231–231. 18 indexed citations
10.
Ferrara, Giovanni, et al.. (2019). Epidemiology of Pulmonary Fibrosis: A Cohort Study Using Healthcare Data in Sweden. Pulmonary Therapy. 5(1). 55–68. 11 indexed citations
11.
Sköld, C. Magnus, Lisen Arnheim‐Dahlström, Karen Bartley, et al.. (2019). Patient journey and treatment patterns in adults with IPF based on health care data in Sweden from 2001 to 2015. Respiratory Medicine. 155. 72–78. 15 indexed citations
12.
Dréno, Brigitte, Paolo A. Ascierto, Victoria Atkinson, et al.. (2018). Health-related quality of life impact of cobimetinib in combination with vemurafenib in patients with advanced or metastatic BRAFV600 mutation–positive melanoma. British Journal of Cancer. 118(6). 777–784. 13 indexed citations
13.
Bartley, Karen, et al.. (2017). P149 Description of a national pulmonary fibrosis cohort in sweden. HighWire Press Open Archive. A164–A165. 1 indexed citations
14.
15.
Clark, M., Susan Martin, Karen Bartley, et al.. (2015). The Impact Of Non-Muscle Invasive Bladder Cancer: Qualitative Research With Patients. Value in Health. 18(7). A471–A471. 3 indexed citations
16.
Bartley, Karen, Kendra DeBusk, & Steven B. Duff. (2015). Health-Related Quality Of Life In Bladder Cancer: A Systematic Literature Review. Value in Health. 18(7). A474–A475. 2 indexed citations
17.
Chokkalingam, Anand P., Karen Bartley, Joseph L. Wiemels, et al.. (2011). Haplotypes of DNA repair and cell cycle control genes, X-ray exposure, and risk of childhood acute lymphoblastic leukemia. Cancer Causes & Control. 22(12). 1721–1730. 22 indexed citations
18.
Chokkalingam, Anand P., Melinda C. Aldrich, & Karen Bartley. (2011). Matching on Race and Ethnicity in Case-Control Studies as a Means of Control for Population Stratification. Epidemiology Open Access. 1(1). 101–101. 11 indexed citations
19.
Bartley, Karen, Catherine Metayer, Steve Selvin, Jonathan M. Ducore, & Patricia A. Buffler. (2010). Diagnostic X-rays and risk of childhood leukaemia. International Journal of Epidemiology. 39(6). 1628–1637. 88 indexed citations
20.
Aldes, L.D., et al.. (1996). Pre- and postnatal development of the catecholamine innervation of the hypoglossal nucleus in the rat: an immunocytochemical study. Developmental Brain Research. 91(1). 83–92. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Flora E. van Leeuwen Breakdown of academic impact, for papers by Timothy A. Zaki Breakdown of academic impact, for papers by Deepa Dhawan Breakdown of academic impact, for papers by Maria Komisarenko Breakdown of academic impact, for papers by Louise M. Rasmussen Breakdown of academic impact, for papers by Jennifer Woo Breakdown of academic impact, for papers by Luis Alberto More Breakdown of academic impact, for papers by Margaret Cupit-Link Breakdown of academic impact, for papers by Stephanie B. Dixon Breakdown of academic impact, for papers by Tayup Şimşek
Rankless by CCL
2026